News

News
Partner news

Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test

Read full story
Partner news

Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform

Read full story
In the media

BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs

Read full story
In the media

As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on

Read full story
Partner news

HistoSonics Announces $40 Million Financing

Read full story
Partner news

Imec collaborates with Janssen to advance precision medicine to treat and eliminate disease

Read full story